Health Care [ 11/12 ] | Biotechnology [ 55/73 ]
NASDAQ | Common Stock
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.
The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis.
It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma.
The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019.
Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 14, 25 | -0.56 Decreased by -143.48% | -0.69 Increased by +18.53% |
| Mar 12, 25 | -0.50 Increased by +35.90% | -0.59 Increased by +14.57% |
| Nov 14, 24 | -0.45 Decreased by -28.57% | -0.40 Decreased by -11.25% |
| Aug 14, 24 | -0.25 Increased by +99.30% | -0.35 Increased by +28.98% |
| May 15, 24 | -0.23 Increased by +47.73% | -0.40 Increased by +42.50% |
| Mar 25, 24 | -0.78 | -0.58 Decreased by -34.48% |
| Nov 13, 23 | -0.35 | -0.99 Increased by +64.65% |
| Aug 21, 23 | -35.80 | -0.50 Decreased by -7.06 K% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by N/A% | -18.18 M Decreased by -174.19% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -16.20 M Decreased by -98.76% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -14.62 M Decreased by -130.11% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.12 M Decreased by -19.65% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -6.63 M Decreased by -0.64% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -8.15 M Decreased by -13.29% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 2.00 M Increased by +N/A% | -6.35 M Increased by +14.92% | Decreased by -317.65% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -6.79 M Increased by +4.46% | Decreased by N/A% - |